* Helius Medical Technologies Inc HSDT.OQ reported a
quarterly
adjusted loss of 99 cents per share for the quarter ended
September 30, higher than the same quarter last year, when the
company reported EPS of $-5.49. The lone analyst forecast for
the quarter was for a loss of $1.06 per share.
* Revenue fell 64.3% to $51.00 thousand from a year ago;
analysts
expected $150.00 thousand.
* Helius Medical Technologies Inc's reported EPS for the
quarter
was a loss of 99 cents.
* The company reported a quarterly loss of $3.69 million.
* Helius Medical Technologies Inc shares had fallen by 19.4%
this
quarter and lost 94.4% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the advanced
medical
equipment & technology peer group is also "hold"
This summary was machine generated from LSEG data November 21 at
11:59 a.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2024 -1.06 -0.99 Beat
Jun. 30 2024 -0.50 -0.64 Missed
Mar. 31 2024 -3.87 -3.08 Beat
Dec. 31 2023 -3.77 -1.47 Beat